| 发明名称 |
COMBINATION TREATMENTS FOR CHEMOKINE-MEDIATED DISEASES |
| 摘要 |
88thods of treating chemokine-mediated diseases are disclosed. The methods comprise the administration of CXC-Chemokine receptor antagonists of the formula (Chemical formula should be inserted here as it appears on abstract in paper form) ,or pharmaceutically acceptable salts or solvates thereof, in combination with other classes of pharmaceutical compounds. The chemokine- mediated diseases include acute and chronic inflammatory disorders, psoriasi s, cystic fibrosis, asthma and cancer. Also disclosed are novel compounds of formula (I).
|
| 申请公布号 |
CA2479126(A1) |
申请公布日期 |
2003.10.02 |
| 申请号 |
CA20032479126 |
申请日期 |
2003.03.17 |
| 申请人 |
SCHERING CORPORATION |
发明人 |
LUNDELL, DANIEL;KREUTNER, WILLIAM;TAVERAS, ARTHUR G.;YU, YOUNONG;JAKWAY, JAMES;BILLAH, MOTASIM;CHAO, JIANHUA;FINE, JAY S.;BIJU, PURAKKATTLE;BOBER, LORETTA A. |
| 分类号 |
C07D295/18;A61K31/166;A61K31/167;A61K31/277;A61K31/341;A61K31/351;A61K31/36;A61K31/381;A61K31/397;A61K31/40;A61K31/401;A61K31/415;A61K31/422;A61K31/427;A61K31/4412;A61K31/4422;A61K31/443;A61K31/455;A61K31/495;A61K31/496;A61K31/505;A61K31/506;A61K31/53;A61K31/5375;A61K45/00;A61K45/06;A61P1/00;A61P1/02;A61P1/04;A61P1/16;A61P1/18;A61P3/00;A61P7/00;A61P7/02;A61P9/00;A61P9/10;A61P11/00;A61P11/02;A61P11/06;A61P11/08;A61P13/12;A61P15/00;A61P17/00;A61P17/02;A61P17/06;A61P19/00;A61P19/02;A61P19/06;A61P19/10;A61P21/00;A61P25/00;A61P25/02;A61P25/28;A61P27/00;A61P27/02;A61P29/00;A61P31/04;A61P31/12;A61P31/16;A61P31/18;A61P33/06;A61P35/00;A61P37/06;A61P37/08;C07D205/04;C07D207/08;C07D207/12;C07D207/333;C07D213/74;C07D213/81;C07D213/82;C07D213/89;C07D231/38;C07D239/42;C07D239/47;C07D241/04;C07D307/52;C07D307/68;C07D309/14;C07D317/58;C07D333/20;C07D333/38;C07D405/06;C07D405/12;C07D409/12;C07D413/12;C07D413/14;(IPC1-7):C07D413/12;A61K31/440 |
主分类号 |
C07D295/18 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
